Therapeutic Potential of Fluoxetine in Neurological Disorders

The selective serotonin reuptake inhibitor (SSRI) fluoxetine, which is registered for a variety of psychiatric disorders, has been found to stimulate the cAMP‐responsive element binding protein (CREB), increase the production of brain‐derived neurotrophic factor (BNDF) and the neurotrophic peptide S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CNS Neurosci Ther
Autors principals: Mostert, Jop P., Koch, Marcus W., Heerings, Marco, Heersema, Dorothea J., De Keyser, Jacques
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Inc 2008
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494017/
https://ncbi.nlm.nih.gov/pubmed/18482027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2008.00040.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars